The first clinical trials of the coronavirus vaccine will be conducted on 60 volunteers. This was announced by the General Director of the state scientific center “Vector” Rinat Maksyutov.
According to him, a list of volunteers has been formed, including vaccine developers. Among them — the chief developer Ilnaz Imatdinov, said Maksyutov in the film naili Asker-zade “Dangerous virus 2” on the TV channel “Russia 1”.
According to the General Director of Vector, clinical trials are conducted on healthy volunteers in accordance with the approved Protocol.
The day before, Vector registered a test system for detecting antibodies to a new coronavirus. The new diagnostic tool will allow you to retrospectively identify patients who have been ill, study immunity, and evaluate the effectiveness of the developed vaccines against COVID-19.
As of April 11, 13,584 cases of coronavirus infection in 82 regions have been registered in Russia since the beginning of the epidemic. At the same time, 106 patients died from the infection, and 1045 were cured.